Dexcom ratios
$83.33+2.38%
In fiscal 2025 (the year to 31 Dec 2025), Dexcom had an operating margin of 19.6%, a return on equity of 34.5%, a return on invested capital of 20.8%.
From Dexcom's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.
Annual
| USD | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 12.3% | 37.9% | 47.1% | 46.6% | 62.6% | 68.0% | 69.3% | 66.0% | 68.5% | 64.4% | 63.1% | 66.4% | 68.6% | 64.7% | 63.2% | 60.5% | 60.1% |
| Operating margin | −154% | −93.2% | −58.7% | −55.8% | −18.1% | −8.3% | −14.2% | −11.1% | −5.9% | −18.1% | 9.6% | 15.5% | 10.9% | 13.4% | 16.5% | 14.9% | 19.6% |
| Net margin | −180% | −114% | −58.6% | −54.6% | −18.6% | −8.6% | −14.3% | −11.4% | −7.0% | −12.3% | 6.8% | 28.5% | 8.9% | 11.7% | 14.9% | 14.3% | 17.9% |
| Free cash flow margin | −143% | −102% | −49.9% | −42.6% | −3.4% | 2.9% | 3.9% | 0.1% | 3.6% | 5.4% | 9.1% | 14.4% | 2.2% | 10.5% | 14.1% | 15.6% | 23.1% |
| Return on equity | — | −259% | −54.0% | −60.1% | −37.0% | −20.0% | −31.9% | −26.0% | −14.3% | −23.5% | 13.1% | 40.6% | 11.2% | 16.3% | 25.8% | 27.6% | 34.5% |
| Return on assets | — | −46.4% | −35.8% | −38.9% | −20.0% | −11.1% | −18.9% | −14.5% | −5.1% | −10.4% | 6.4% | 7.1% | 4.9% | 6.6% | 7.8% | 7.6% | 10.9% |
| Return on capital employed | — | −73.0% | −53.4% | −57.9% | −32.7% | −18.3% | −30.9% | −24.3% | −8.0% | −15.2% | 7.6% | 10.5% | 6.7% | 10.1% | 14.5% | 14.5% | 23.5% |
| Return on invested capital | — | −194% | −161% | −136% | −58.5% | −33.3% | −51.1% | −34.7% | −16.9% | −42.9% | 13.3% | 10.5% | 9.5% | 15.7% | 20.0% | 17.9% | 20.8% |
| Current ratio | — | 4.32 | 7.11 | 3.98 | 2.90 | 3.59 | 3.46 | 2.73 | 5.36 | 7.64 | 5.47 | 5.58 | 5.11 | 1.99 | 2.84 | 1.47 | 1.88 |
| Debt to equity | — | — | — | 0.09 | 0.08 | 0.03 | — | 0.00 | 0.78 | 1.52 | 1.30 | 0.98 | 1.03 | 0.62 | 1.23 | 0.63 | 0.49 |
| Net debt / EBITDA | — | — | — | — | — | — | — | — | — | — | 3.66 | 2.64 | −0.85 | −2.08 | −0.24 | −1.24 | 0.36 |
| Interest coverage | −5.70 | −30.20 | −4072.73 | −278.50 | −32.11 | −26.88 | −142.75 | −91.29 | −3.32 | −8.21 | 2.36 | 16.92 | 14.14 | 26.61 | 36.45 | 40.27 | 63.76 |
| Cash conversion | 79.2% | 89.9% | 85.2% | 78.2% | 18.5% | −33.0% | −27.3% | −0.8% | −51.8% | −44.1% | 133% | 50.3% | 24.6% | 89.3% | 94.5% | 109% | 129% |
| SBC / Revenue | 28.2% | 19.3% | 17.7% | 18.4% | 15.4% | 19.3% | 20.6% | 19.3% | 14.8% | 9.9% | 7.0% | 6.2% | 4.6% | 4.3% | 4.2% | 4.2% | 3.4% |
Quarterly
| USD | Q4 FY2023 | Q1 FY2024 | Q2 FY2024 | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 63.5% | 61.0% | 62.4% | 59.7% | 58.9% | 56.9% | 59.5% | 60.5% | 62.9% | 62.9% | 63.4% | 64.3% |
| Operating margin | 21.0% | 11.0% | 15.7% | 15.3% | 17.0% | 12.9% | 18.4% | 20.1% | 25.6% | 21.4% | 24.3% | 24.3% |
| Net margin | 24.8% | 15.9% | 14.3% | 13.5% | 13.6% | 10.2% | 15.5% | 23.5% | 21.2% | 16.7% | 19.0% | 20.5% |
| Free cash flow margin | 7.8% | 16.5% | 21.2% | 8.9% | 15.9% | 9.3% | 18.1% | 47.9% | 15.3% | 37.7% | 14.1% | 20.3% |
| Return on equity | 12.4% | 6.5% | 5.9% | 6.8% | 7.2% | 4.7% | 7.0% | 10.4% | 9.7% | 6.7% | 9.5% | 10.9% |
| Return on assets | 2.7% | 1.2% | 1.8% | 1.8% | 2.1% | 1.4% | 2.2% | 2.6% | 4.0% | 2.8% | 3.9% | 4.3% |
| Return on capital employed | 4.6% | 2.1% | 3.1% | 3.3% | 5.3% | 3.6% | 5.3% | 5.8% | 7.7% | 5.8% | 7.8% | 8.2% |
| Return on invested capital | 8.5% | 3.5% | 5.6% | 4.8% | 4.0% | 2.7% | 3.9% | 5.5% | 7.7% | 5.7% | 8.3% | 8.8% |
| Current ratio | 2.84 | 2.90 | 2.82 | 2.46 | 1.47 | 1.50 | 1.52 | 1.56 | 1.88 | 1.95 | 1.73 | 1.74 |
| Debt to equity | 1.23 | 1.13 | 1.04 | 1.28 | 0.63 | 0.58 | 0.51 | 0.48 | 0.49 | 0.45 | 0.51 | 0.53 |
| Net debt / EBITDA | −0.71 | −0.58 | −2.06 | 1.26 | −4.10 | −5.91 | 0.57 | −1.70 | 1.08 | 0.66 | 0.62 | 0.95 |
| Interest coverage | 55.62 | 27.32 | 41.58 | 41.08 | 51.05 | 36.14 | 55.95 | 65.54 | 104.19 | 121.57 | 144.68 | 155.81 |
| Cash conversion | 31.6% | 104% | 149% | 65.6% | 117% | 91.8% | 116% | 204% | 71.9% | 225% | 74.1% | 99.1% |
| SBC / Revenue | 3.6% | 4.2% | 4.5% | 4.4% | 3.9% | 3.3% | 3.9% | 3.7% | 2.8% | 3.6% | 3.0% | 2.7% |
The main figures as JSON and plain text. See data and methodology.
DXCM in the terminal
Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.
